Skip to content

Bilateral Total Knee Arthroplasty vs Unicompartment Arthroplasty Retrospective and Clinical Outcome Study

A Retrospective Consecutive Series Patient Preference and Clinical Outcomes Study in Bilateral Knee Osteoarthritis Patients With Both Total Knee Arthroplasty and Unicompartment Knee Arthroplasty Prostheses.

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02583113
Enrollment
0
Registered
2015-10-21
Start date
2016-02-29
Completion date
2026-12-01
Last updated
2023-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Keywords

Total Knee Replacement, Unicompartment Knee Replacement

Brief summary

To determine if there is a patient satisfaction preference of Total Knee Arthroplasty (TKA) vs Unicompartmental Knee Arthroplasty (UKA) in patients with bilateral knee osteoarthritis who underwent a primary TKA one side and a primary UKA on the opposite side and are at a minimum of two years post-surgery. Patient reported outcomes and data with be analyzed along with all retrospective chart data.

Interventions

DEVICETotal and Unicompartment Knee Replacement

Patients who have undergone a primary TKA on one side and primary UKA on the opposite side and are at a minimum of two years post-surgery.

Sponsors

Medacta USA
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Must be able to read, understand and provide written informed consent on the Institutional Review Board (IRB) approved Informed Consent Form (ICF) 2. Ability to understand and provide written authorization for use and disclosure of personal health information 3. Subject who are able and willing to comply with the study protocol and follow-up visit 4. Must be 18 years or older to participate 5. Subjects must have a clinically documented osteoarthritis in both knees, single or multiple compartments 6. Subjects must have undergone a primary TKA and primary UKA in the contralateral knee 7. Must be a minimum 2 year (24 months) post-surgery on each knee 8. One or both TKA/UKA surgeries must have been performed by the Principal Investigator. 9. Subjects must be able to return for the follow-up appointment, and have the mental capacity to cooperate with PRO's, questionnaires, physical exam and radiographs

Exclusion criteria

1. Subjects who underwent UKA with Patella Femoral Joint (PFJ) replacement on the same side. 2. Women who are pregnant

Design outcomes

Primary

MeasureTime frameDescription
To evaluate patient preference of Total Knee Arthroplasty (TKA) vs Unicompartmental Knee Arthroplasty (UKA)Minimum 2 years post surgeryAsking patients which is your better knee overall

Secondary

MeasureTime frameDescription
Knee Injury and Osteoarthritis Outcome Score (KOOS)Minimum 2 years post-opKnee symptoms, pain, function, and QoL
Forgotten Joint Score (FJS)Minimum of 2 years post-opKnee function-patient's ability to forget the artificial joint in everyday life
Knee Society Score (KSS) subjective measuresMinimum of 2 years post-opPatient Expectation and Satisfaction Sub-scores
Euro-Qual Health Related Quality of Life (EQ-5D)Minimum of 2 years post-opGeneral health status
Radiographic AnalysisPre-operative and minimum of 2 years post-opRadiographic analysis will include evaluation of component and limb alignment, evidence of component subsidence or migration, and the presence and progression of radiolucent lines between the prosthesis, bone and cement.
Knee Society Score (KSS) Objective measuresMinimum of 2 years post-op
DemographicsPre-operative and Minimum of 2 years post-op
Return to work historyMinimum of 2 years post-opQuestionnaire for work history prior to surgery and after surgery

Other

MeasureTime frame
Complications will be recordedPre-operative and minimum 2 years post-operative

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026